These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9514874)

  • 1. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
    Nuckolls FJ; Khan AS; Butler R; Katula KS
    Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A.
    Katula KS; Fields A; Apple P; Rotruck T
    Arch Biochem Biophys; 2002 May; 401(2):271-6. PubMed ID: 12054478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
    Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
    Motwani M; Li X; Schwartz GK
    Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.
    Katula KS; Wright KL; Paul H; Surman DR; Nuckolls FJ; Smith JW; Ting JP; Yates J; Cogswell JP
    Cell Growth Differ; 1997 Jul; 8(7):811-20. PubMed ID: 9218875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
    Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
    Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclins and Cdks on the cyclin B1 promoter activation.
    Moro A; Zerfass K; Joswig S; Jansen-Duerr P
    Biochem Mol Biol Int; 1997 Apr; 41(5):919-24. PubMed ID: 9137822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
    O'Brien V; Campo MS
    Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
    David-Pfeuty T
    Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.
    Abraham RT; Acquarone M; Andersen A; Asensi A; Bellé R; Berger F; Bergounioux C; Brunn G; Buquet-Fagot C; Fagot D
    Biol Cell; 1995; 83(2-3):105-20. PubMed ID: 7549905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells.
    Barrett KL; Demiranda D; Katula KS
    Cell Biol Int; 2002; 26(1):19-28. PubMed ID: 11779217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication.
    Gong J; Traganos F; Darzynkiewicz Z
    Cell Growth Differ; 1995 Nov; 6(11):1485-93. PubMed ID: 8562487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
    Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
    Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
    Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
    Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
    Rooney RJ
    Cell Growth Differ; 2001 Oct; 12(10):505-16. PubMed ID: 11682462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of cyclin B1 gene transcription in quiescent NIH3T3 cells is mediated by an E-box.
    Farina A; Gaetano C; Crescenzi M; Puccini F; Manni I; Sacchi A; Piaggio G
    Oncogene; 1996 Sep; 13(6):1287-96. PubMed ID: 8808703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A S/M DNA replication checkpoint prevents nuclear and cytoplasmic events of cell division including centrosomal axis alignment and inhibits activation of cyclin-dependent kinase-like proteins in fucoid zygotes.
    Corellou F; Bisgrove SR; Kropf DL; Meijer L; Kloareg B; Bouget FY
    Development; 2000 Apr; 127(8):1651-60. PubMed ID: 10725241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.